Professor David Price
Editor-In-Chief: Professor David Price, FRCGP, UK
David Price completed his medical degree at Cambridge University in 1984 and his general practitioner training in Norwich in 1989. Between 1990 and 2000, he worked as a principal in general practice in Norwich, and he continues to work there as a GP with a special interest in respiratory disease. David Price is currently the Primary Care Respiratory Society Professor of Primary Care Respiratory Medicine at the University of Aberdeen, Scotland. He is the founder and managing director of Research in Real Life in UK, and founder and director of Optimum Patient Care in UK and Observational & Pragmatic Research Institute in Singapore.
David Price is extensively involved in respiratory and allergy education and research. His areas of interest are ‘real-life’ effectiveness and cost-effectiveness of interventions, clinical trial design, compliance, and patient attitudes to their disease. He has authored over 300 peer-reviewed publications since 2000 and is responsible for approximately US$20 million in research and clinical development grants. David Price founded the Respiratory Effectiveness Group (www.effectivenessevaluation.org), a not-for-profit, investigator-led initiative, which uses an international collaborative approach to explore the role of real-life research in informing clinical guidelines and improving patient care.